On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suited for long-term investment strategies.
226 - 250 of 89.520
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Lam Research Call 325,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,52x
- Analysis
- Lam Research Call 335,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,23x
- Analysis
- Lam Research Call 315,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,10x
- Analysis
- Pfizer Call 40,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 4,09x
- Analysis
- Danaher Call 215,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,58x
- Analysis
- Lam Research Call 315,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,49x
- Analysis
- Biontech Se USD Call 112,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,92x
- Analysis
- Biontech Se USD Call 102,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,87x
- Analysis
- Biontech Se USD Call 114,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,95x
- Analysis
- Biontech Se USD Call 106,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,89x
- Analysis
- Biontech Se USD Call 96,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,84x
- Analysis
- Biontech Se USD Call 92,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,82x
- Analysis
- Biontech Se USD Call 112,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 2,03x
- Analysis
- Biontech Se USD Call 92,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,89x
- Analysis
- Biontech Se USD Call 96,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,92x
- Analysis
- Biontech Se USD Call 98,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,94x
- Analysis
- Biontech Se USD Call 104,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,98x
- Analysis
- Biontech Se USD Call 104,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,09x
- Analysis
- Biontech Se USD Call 114,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,18x
- Analysis
- Biontech Se USD Call 106,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,11x
- Analysis
- Biontech Se USD Call 98,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,04x
- Analysis
- Biontech Se USD Call 94,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,00x
- Analysis
- Biontech Se USD Call 112,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,24x
- Analysis
- ASML Call 1.320,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,14x
- Analysis
- Biontech Se USD Call 92,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,00x
- Analysis